FDA Nod for BridgeBio Brings New Competition to Blockbuster Pfizer Cardio Drug
MedCity News
NOVEMBER 25, 2024
But new competition to both products could come soon from Alnylam Pharmaceuticals, now set to receive an FDA decision in this indication by late March. The post FDA Nod for BridgeBio Brings New Competition to Blockbuster Pfizer Cardio Drug appeared first on MedCity News.
Let's personalize your content